{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:15Z","timestamp":1786986915275,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.clbc.2013.12.008","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T16:31:57Z","timestamp":1388766717000},"page":"291-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Does Obesity Interfere With Anastrozole Treatment? Positive Association Between Body Mass Index and Anastrozole Plasma Levels"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael","family":"Hubalek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Oberguggenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Meraner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sztankay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Oberacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birthe","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Giesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Kemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Holzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sperner-Unterweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2013.12.008_bib1","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.2010.33.2585","article-title":"Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial","volume":"29","author":"Pfeiler","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10549-010-1101-y","article-title":"Commentary on: \u201cEffect of obesity on survival in women with breast cancer: systematic review and meta-analysis\u201d (Melinda Protani, Michael Coory, Jennifer H. Martin)","volume":"123","author":"Goodwin","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2013.12.008_bib3","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","article-title":"Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial","volume":"28","author":"Sestak","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/annonc\/mdh222","article-title":"Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience","volume":"15","author":"Berclaz","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1038\/bjc.2012.473","article-title":"Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index","volume":"107","author":"Sendur","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2013.12.008_bib7","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1200\/JCO.2012.43.7244","article-title":"Aromatase inhibition in obese women: how much is enough?","volume":"30","author":"Ligibel","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib8","first-page":"55a","article-title":"The efficacy of anastrozole is not dependent upon body mass index (BMI) in postmenopausal women with advanced breast cancer (BC)","volume":"21","author":"Michaud","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib9","first-page":"103a","article-title":"Body mass index as predictive parameter for response and time to progression (TTP) in advanced breast cancer patients treated with letrozole or megestrol acetate","volume":"19","author":"Schmid","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clbc.2013.12.008_bib10","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/bjc.2013.499","article-title":"Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer","volume":"109","author":"Pfeiler","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2013.12.008_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.clbc.2013.12.008_bib12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00216-010-4075-z","article-title":"Development and validation of\u00a0a\u00a0liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study","volume":"398","author":"Beer","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.clbc.2013.12.008_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/j.clbc.2013.12.008_bib14","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.breast.2013.07.008","article-title":"Obesity and endocrine therapy: host factors and breast cancer outcome","volume":"22","author":"Goodwin","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2013.12.008_bib15","first-page":"552","article-title":"Adjuvant aromatase inhibitor options in overweight and obese postmenopausal women with breast cancer","volume":"19","author":"Chlebowski","year":"2013","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2013.12.008_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/bja\/85.1.91","article-title":"Obesity in anaesthesia and intensive care","volume":"85","author":"Adams","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clbc.2013.12.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/js980173a","article-title":"Pharmacokinetic considerations in obesity","volume":"88","author":"Blouin","year":"1999","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.clbc.2013.12.008_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/bjc.2013.367","article-title":"The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial","volume":"109","author":"Gnant","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2013.12.008_bib19","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/0008-5472.CAN-09-3024","article-title":"Variation in anastrozole metabolism and\u00a0pharmacodynamics in women with early breast cancer","volume":"70","author":"Ingle","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2013.12.008_bib20","article-title":"Arimidex: Non-Steroidal Aromatase Inhibitor [product monograph]","year":"2011","journal-title":"AstraZeneca"},{"key":"10.1016\/j.clbc.2013.12.008_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1054\/bjoc.2001.1925","article-title":"Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex and tamoxifen alone or in combination' (ATAC) trial","volume":"85","author":"Dowsett","year":"2001","journal-title":"Br J Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820913003133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820913003133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:12:54Z","timestamp":1761513174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820913003133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1526820913003133"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2013.12.008","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does Obesity Interfere With Anastrozole Treatment? Positive Association Between Body Mass Index and Anastrozole Plasma Levels","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2013.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}